Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Winston

Showing results (221-230 of 241) with videos related to

Pageof 25
Sort By:
HIV Medicine|December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022Laura Waters, Alan Winston, Iain Reeves, et al.
AIDS Research and Human Retroviruses|November 2, 2022
Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging WorkshopXiaoying Yu, Judith D Lobo, Erin Sundermann, et al.
HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.
The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.
AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.
Neurology|March 5, 2017
Increased brain-predicted aging in treated HIV diseaseJames H Cole, Jonathan Underwood, Matthan W A Caan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2018
No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) ProjectJames H Cole, Matthan W A Caan, Jonathan Underwood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 StudyJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Neurology|June 8, 2014
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsEllen C Caniglia, Lauren E Cain, Amy Justice, et al.
HIV Medicine|August 30, 2016
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Duncan Churchill, Laura Waters, Nadia Ahmed, et al.
Pageof 25

Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
HIV Medicine|December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022Laura Waters, Alan Winston, Iain Reeves, et al.
AIDS Research and Human Retroviruses|November 2, 2022
Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging WorkshopXiaoying Yu, Judith D Lobo, Erin Sundermann, et al.
HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.
The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.
AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.
Neurology|March 5, 2017
Increased brain-predicted aging in treated HIV diseaseJames H Cole, Jonathan Underwood, Matthan W A Caan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2018
No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) ProjectJames H Cole, Matthan W A Caan, Jonathan Underwood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 StudyJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Neurology|June 8, 2014
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsEllen C Caniglia, Lauren E Cain, Amy Justice, et al.
HIV Medicine|August 30, 2016
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Duncan Churchill, Laura Waters, Nadia Ahmed, et al.
Pageof 25